Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Feb 25, 2022 · 10-K · 56 days after period end · 0001077183-22-000017
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $125.73M | $126.00M | $106.87M | $76.48M |
| Net Income | -$41.76M | $15.42M | $6.30M | $353.00K |
| EPS Diluted | — | — | $0.06 | $0.00 |
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2021 · filed Feb 25, 2022 · 56 d after period end
